Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Stryker Corporation (NYSE: SYK) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a rich history dating back to 1941 and headquartered in..
ResMed Inc. (NYSE: RMD) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $39.57 billion, this San..
GE HealthCare Technologies Inc. (NYSE: GEHC) stands out as a compelling opportunity in the healthcare sector, particularly for investors seeking exposure to health information services with promising growth prospects. Headquartered..
Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to treating RAS-addicted cancers. Specializing in precision oncology, this Redwood..
Prestige Consumer Healthcare Inc. (NYSE: PBH) is a significant player in the healthcare sector, specializing in the development and distribution of over-the-counter (OTC) health and personal care products across the..
Incyte Corporation (NASDAQ: INCY) has carved a niche in the biotechnology sector with its innovative biopharmaceutical solutions. As a prominent player in healthcare, Incyte is engaged in the discovery, development,..
DexCom, Inc. (NASDAQ: DXCM), a leader in the medical devices sector, continues to capture investor attention with its innovative continuous glucose monitoring (CGM) systems. With a market capitalization of $26.31..
Guardant Health, Inc. (GH), a trailblazer in precision oncology, is capturing investor attention with its innovative approach to cancer diagnostics and a notable potential upside of 11.76%. As a player..
Tempus AI, Inc. (TEM), a prominent player in the healthcare technology sector, has caught the attention of investors with its impressive growth metrics and strategic collaborations. Based in Chicago, Illinois,..
Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is drawing the attention of investors with its significant growth prospects and a strategic footprint in the medical..
Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. Headquartered in Melville, New York, the company holds a market..
Takeda Pharmaceutical Company Limited (TAK), a venerable name in the healthcare sector, presents an intriguing investment opportunity primarily due to its expansive pipeline and robust market position. With a market..
Investors eyeing the healthcare technology sector might want to take a closer look at Veeva Systems Inc. (NYSE: VEEV), a prominent player in providing cloud-based software solutions tailored for the..
UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, continues to command investor interest despite recent market volatility. With a current market capitalization of $311.62 billion, UnitedHealth is..
Royalty Pharma plc (NASDAQ: RPRX), a pioneering entity in the biopharmaceutical royalty sphere, presents an intriguing opportunity for investors seeking both stability and growth within the healthcare sector. With a..
Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, is a key provider of healthcare plans in the United States. With a market capitalization of $17.12 billion, Centene..
Investors looking to capitalize on growth opportunities in the biotechnology sector might find Axsome Therapeutics, Inc. (NASDAQ: AXSM) an intriguing prospect. With a market cap of $5.83 billion, this New..
Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, continues to attract investor attention with its strong market presence and promising financials. As a key player in..
Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is capturing investor attention with a compelling potential upside of 42.65%...
Roivant Sciences Ltd. (NASDAQ: ROIV), a clinical-stage biopharmaceutical company, has been garnering significant attention from investors, particularly given its position in the rapidly evolving biotechnology sector. Based in London, United..
